Post by
bioboy10 on Jan 11, 2010 7:19pm
Analyst recommendation
New recommendation from analysts following;
versant - 12 month target $1.75
LOM - 12 month target $1.50
Next critical date - 6 month followup and to see a upward trend in ipss improvement with 302 compound and a stabilizing effect in ipss with placebo.
Comment by
cabbieJBJ on Jan 11, 2010 9:15pm
Bioboy - do you have copies or a link to the recos? Much appreciated. Thx, in advance. jb